Vedolizumab is Safe and Effective in the Treatment of X-linked Agammaglobulinemia-Associated Inflammatory Bowel Disease.
The journal of allergy and clinical immunology In practice（2020）
关键词
Treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
The journal of allergy and clinical immunology In practice（2020）